Resilience in the face of pelvic pain: A pilot study in males and females affected by urologic chronic pelvic pain
article
OA: gold
CC0
⤵ 3 in-corpus citations
Abstract
AIMS: Resilience represents a fundamental element in the experience of pain, as it allows adaptation to suffering and increases psychological social well-being and quality of life (QoL). We investigated resilience in patients affected by urologic chronic pelvic pain (UCPP) and the relationships with pain severity and distribution, catastrophizing and psychological distress. METHODS: Forty-eight consecutive UCPP patients were classified on a pain body map as being affected by pelvic pain only or widespread pain (WP), and underwent the evaluation of resilience with the 14-item Resilience Scale (RS-14), with higher scores indicating high resilience levels; scores < 56 denote very poor resilience. Pelvic and nonpelvic pain intensity and the bother of urinary symptoms on QoL were measured by means of Pain Numerical Rating Scale (PNRS) and Visual Analog Scale (VAS). Pain Catastrophizing Scale (PCS) and Depression Anxiety Stress Scales (DASS-21) investigated catastrophizing and psychological conditions. RESULTS: Overall, RS-14 mean ± SD total score was 50.2 ± 12.5 in patients with pelvic pain only and 40.2 ± 10.2 in those with WP. Significant relationships were observed between low resilience levels and high scores of pelvic and nonpelvic PNRS, VAS, pain catastrophizing scale and depression and anxiety, stress scale (for all: p < 0.001). Significantly lower RS-14 scores were detected in females and in patients with WP. CONCLUSIONS: A very poor resilience has been identified in UCPP patients, particularly in those with greater catastrophizing and mood alterations. WP and female gender were mostly affected. In UCPP patients, low resilience appears as a crucial factor in pain experience.
My notes (saved in your browser only)
Outcome instruments
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (4)
- Characterization of Whole Body Pain in Urological Chronic Pelvic Pain Syndrome at Baseline: A MAPP Research Network Study 2017
- Resilience in the face of pelvic pain: A pilot study in males and females affected by urologic chronic pelvic pain 2021
- Chronic Pelvic Pain Patients Demonstrate Higher Catastrophizing in Association with Pelvic Symptoms and Comorbid Pain Diagnoses 2020
- Continuing care for patients affected by urologic chronic pelvic pain in the era of severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) pandemic 2020
Cited by (3)
References (31)
- Characterization of Whole Body Pain in Urological Chronic Pelvic Pain Syndrome at Baseline: A MAPP Research Network Study via openalex
- Chronic Pelvic Pain Patients Demonstrate Higher Catastrophizing in Association with Pelvic Symptoms and Comorbid Pain Diagnoses via openalex
- Continuing care for patients affected by urologic chronic pelvic pain in the era of severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) pandemic via openalex
- Resilience in the face of pelvic pain: A pilot study in males and females affected by urologic chronic pelvic pain via openalex
- W1997517088 via openalex
- W2000428417 via openalex
- W2000653311 via openalex
- W2005557882 via openalex
- W2010293445 via openalex
- W2016161880 via openalex
- W2016708144 via openalex
- W2018811661 via openalex
- W2050180989 via openalex
- W2052967212 via openalex
- W2064475745 via openalex
- W2082380750 via openalex
- W2135809676 via openalex
- W2152467814 via openalex
- W2161807262 via openalex
- W2528239438 via openalex
- W2606878819 via openalex
- W2795585082 via openalex
- W2809244537 via openalex
- W2903361339 via openalex
- W2954874884 via openalex
- W2990924761 via openalex
- W1510780496 via openalex
- W6770590825 via openalex
- W1976512343 via openalex
- W1978778965 via openalex
- W1989866986 via openalex
Cited by (3)
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK